Last Updated: August 9, 2026

Patent: 10,246,522


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,246,522
Title:Cellulose particulate material
Abstract:The invention relates to plant-derived cellulose-containing particles useful as strengthening agents in water based systems and to a process for preparing cellulose-containing particles from plant material, which process involves treating said plant material with a peroxide reagent. The process can be controlled to produce cellulose-containing particle having a viscosity up to about 2500 cps.
Inventor(s):David Hepworth, Eric Whale
Assignee: Cellucomp Ltd
Application Number:US14/778,368
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

error: insufficient information

More… ↓

⤷  Start Trial

Details for Patent 10,246,522

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Janssen Biotech, Inc. SIMPONI golimumab Injection 125289 April 24, 2009 ⤷  Start Trial 2034-03-18
Janssen Biotech, Inc. SIMPONI golimumab Injection 125289 May 15, 2013 ⤷  Start Trial 2034-03-18
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 10,246,522

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2014147393 ⤷  Start Trial
World Intellectual Property Organization (WIPO) 2014147392 ⤷  Start Trial
United States of America 2019330381 ⤷  Start Trial
United States of America 2019322768 ⤷  Start Trial
United States of America 2016168274 ⤷  Start Trial
United States of America 2016168273 ⤷  Start Trial
United States of America 10894890 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.